Skip to main content
SpringerLink
Log in

Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Various population studies have reported the association of rare S2 allele of apolipoprotein C3 (APOC3) SstI polymorphism with hypertriglyceridemia (HTG) and coronary artery disease (CAD). We were the first to report an association of S2 allele with high triglyceride (TG) levels in healthy volunteers from Northern India. Since HTG is suggested to be a predominant risk factor for CAD among Indians, we have elucidated the relationship of APOC3 SstI polymorphism with the lipid profile and CAD. A total of 158 patients with ≥ 70% stenosis in one or more coronary artery (angiographically proven CAD patients), 35 subjects with < 70% stenosis (NCAD) and 151 normal controls (free of heart disease) from Northern plains of India were recruited in the study. DNA samples were analyzed by polymerase chain reaction (PCR) followed by SstI digestion. Lipid profile was estimated by enzymatic kit. We found a strong association of S2 allele with high TG levels, which was more significant in patients. Prevalence of S2 allele in normal controls and CAD patients were comparable, despite the fact that mean TG level was significantly higher in patients. A greater insight into this observation revealed that the prevalence of high TG, if not coupled with other risk factors (like high total cholesterol, low HDL), was comparable in patients and controls. Thus, our study reveals that rare S2 allele may be employed as a susceptibility marker for high TG. However, high TG or S2 allele alone may not contribute to the etiology of CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Karanthansis SK: Apolipoprotein multigene family: Tandem organization of human apolipoprotein AI, CIII and AIV genes. Proc Natl Acad Sci USA 82: 6374-6378, 1985

    PubMed  Google Scholar 

  2. Paul-Hayase H, Rosseneu M, Robinson D, Burliet JPV, Deslypere JP, Humphries SE: Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88: 439-446, 1992

    PubMed  Google Scholar 

  3. Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ: Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. J Clin Invest 76: 1090-1095, 1985

    PubMed  Google Scholar 

  4. Stocks J, Paul-Hayase H, Galton DJ: Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-I C-III A-IV gene region and hypertriglyceridemia. Am J Hum Genet 41: 106-118, 1987

    PubMed  Google Scholar 

  5. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL: An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90: 4562-4566, 1993

    PubMed  Google Scholar 

  6. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE: Genetic markers in the apoAI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 100: 157-169, 1993

    Article  PubMed  Google Scholar 

  7. Hoffer MJV, Sijbrands EJ, De Man FH, Havekes LM, Smelt AH, Frants RR: Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. Eur J Clin Invest 28: 807-812, 1998

    Article  PubMed  Google Scholar 

  8. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS, Chiang CW, Lee YS: Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 100: 327-333, 1997

    Article  PubMed  Google Scholar 

  9. Ahn YI, Valdez R, Reddy AP, Cole SA, Weiss KM, Ferrell RE: DNA polymorphisms of the apolipoprotein AI/CIII/AIV gene cluster influences plasma cholesterol and triglyceride levels in the Mayans of the Yucatan peninsula, Mexico. Hum Hered 41: 281-289, 1991

    PubMed  Google Scholar 

  10. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J: An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 95: 371-375, 1995

    Article  PubMed  Google Scholar 

  11. Hong SH, Park WH, Lee CC, Song JH, Kim JQ: Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem 43: 13-17, 1997

    PubMed  Google Scholar 

  12. Rees A, Shoulder CC, Stocks J, Galton DJ, Baralle FE: DNA polymorphisms adjacent to human A-I gene: Relation to hypertriglyceridaemia. Lancet 1: 444-446, 1983

    Article  PubMed  Google Scholar 

  13. Henderson HE, Landen SV, Michie J, Berger GMB: Association of DNA polymorphism in the apolipopoprotein CIII gene with diverse hyperlipidaemic phenotypes. Hum Genet 75: 62-65, 1987

    PubMed  Google Scholar 

  14. Tas S: Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein C-III gene with common hypertriglyceridemia in Arabs. Clin Chem 35: 256-259, 1989

    PubMed  Google Scholar 

  15. Aalto-Setala K, Kontula K, Sane T, Nieminen M, Nikkila E: DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis 66: 145-152, 1987

    Article  PubMed  Google Scholar 

  16. Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TW: Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res 37: 136-147, 1996

    PubMed  Google Scholar 

  17. Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, Cantor RM, Bu X, Lusis AJ, de Bruin TW: Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. J Clin Invest 99: 953-961, 1997

    PubMed  Google Scholar 

  18. Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, de Fazio A, Versaci F, Gioffre PA, Cox NJ: Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children. Hum Genet 98: 557-566, 1996

    Article  PubMed  Google Scholar 

  19. Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, Gilligan M, Gambert P, Ball MJ: Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 87: 239-247, 1991

    Article  PubMed  Google Scholar 

  20. Ferns GAA, Stocks J, Ritchie C, Galton D: Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet ii: 300-303, 1985

    Article  Google Scholar 

  21. Ferns GAA, Stocks J, Galton DJ: C-III DNA restriction fragment length polymorphism and myocardial infarction. Lancet i: 294, 1986

    Google Scholar 

  22. Rees A, Stocks J, Williams LG, Caplin JL, Jowett NI, Camm AJ, Galton DJ: DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis 58: 269-27, 1985

    Article  PubMed  Google Scholar 

  23. Deeb S, Failor A, Brown BG, Brunzell JD, Albers JJ, Motulsky AG: Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harb Symp Quant Biol 51: 403-409, 1986

    PubMed  Google Scholar 

  24. Trembath RC, Thomas DJB, Hendra TJ, Yudkin JS, Galton DJ: Deoxyribonucleic acid polymorphism of the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease in non insulin dependent diabetes. Br Med J 294: 1577-1578, 1987

    Google Scholar 

  25. Breslow JL: Familial disorders of high density lipoprotein metabolism. In: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (eds). The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, 1995, pp 1251-1266

    Google Scholar 

  26. Wang CS, McConathy WJ, Kloer HU, Alaupovic P: Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 75: 384-390, 1985

    PubMed  Google Scholar 

  27. Aalto-Setala K, Weinstock PH, Bisgaier CL, Wu L, Smith JD, Breslow JL: Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice. J Lipid Res 37: 1802-1811, 1996

    PubMed  Google Scholar 

  28. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL: Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 90: 1889-1900, 1992

    PubMed  Google Scholar 

  29. Ito Y, Azrolan N, Connell A, Walsh A, Breslow JL: Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249: 790-793, 1990

    PubMed  Google Scholar 

  30. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J: Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269: 23610-23616, 1994.

    PubMed  Google Scholar 

  31. Chhabra S, Narang R, Krishnan LR, Vasisht S, Agarwal DP, Srivastava LM, Manchanda SC, Das N: Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. BMC Genetics 3: 9, 2002

    Article  PubMed  Google Scholar 

  32. Kaul U, Sapra R, Ghose T: Dyslipidemia in Indians. In: K.K. Sethi (eds). Coronary Artery Disease in Indians: A Global Perspective. Monograph commemorating the golden jubilee of cardiological society of India. 1998, pp 83-91.

  33. Mount JN, Kearney EM, Rosseneu M, Slavin BM: Immunoturbidemetric assays for serum apolipoprotrein A1 and B using Cobas biocentrifugal analyzer. J Clin Pathol 41: 471-474, 1988

    PubMed  Google Scholar 

  34. Miller SA, Dykes DD, Polesky HF: A salting out procedure for extracting DNA from human nucleated cells. Nucleic acid Res 16: 1215, 1988

    PubMed  Google Scholar 

  35. Raymond ML, Rousset F: An exact test for population differentiation. Evolution 49:1280-1283, 1995

    Google Scholar 

  36. Bai H, Saku K, Liu R, Imamura M, Arakawa K: Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 95: 102-104, 1995

    Article  PubMed  Google Scholar 

  37. Rees A, Stocks J, Paul-Hayase H, Ohuchi Y, Galton D: Haplotypes identified by DNA polymorphisms at the apolipoprotein A-I and C-III loci and hypertriglyceridemia: A study in a Japanese population. Hum Genet 72: 168-171, 1986

    Article  PubMed  Google Scholar 

  38. Price WH, Morris SW, Burgon R, Donald PM, Kitchin AH: Apolipoprotein CIII polymorphism and coronary heart disease. Lancet 2: 1041, 1986

    Article  Google Scholar 

  39. Wu JH, Kao J-T, Wen M-S, Lo S-K: DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: Correlation of plasma APO CIII with triglyceride level and body mass index. J Formos Med Assoc 99: 367-374, 2000

    PubMed  Google Scholar 

  40. Johansen K, Dunn B, Tan JCY, Kwassi AAA, Skootnicki A, Skootnicki M: Coronary artery disease and apolioprotein AI-CIII p gene polymorphism: A study of Saudi Arabians. Clin Genet 39: 1-5, 1991

    PubMed  Google Scholar 

  41. Liu R, Bai H, Liu Y, Hyang M, Liu B: Apolipoprotein CIII gene SstI polymorphism in patients with endogenous hypertriglyceridemia in Chinese populations. Hua Xi Yi Ke Da Xue Xue Bao 32: 175-178, 2001

    PubMed  Google Scholar 

  42. Buzza M, Fripp Y, Mitchell RJ: Apolipoprotein AI and CIII gene polymorphisms and their association with Lipid levels in Italian, Greek and Anglo-Irish populations of Australia. Ann Hum Biol 28: 481-490, 2001

    Article  PubMed  Google Scholar 

  43. Tas S, Abdella NA: Blood pressure, coronary artery disease and glycaemic control in type 2 diabetes mellitus: Relation to Apolipoprotein C-III gene polymorphism. Lancet 343: 1194-1195, 1994

    Article  PubMed  Google Scholar 

  44. Pérez-Jiménez F, López-Miranda J, Gómez P, Velasco MJ, Marín C, Pérez-Martínez P, Moreno JA, Paniagua JA: The SstI polmorphism of the apoC-III gene is associated with insulin sensitivity in young men. Diabetologia 45: 1196-1200, 2002

    PubMed  Google Scholar 

  45. Salas J, Jansen S, López-Miranda J, Ordovas JM, Castro P, Marin C, Ostos MA, Bravo MD, Jimenez-Pereperez J, Blanco A, Lopez-Segura F, Perez-Jimenez F: The SstI polymorphism of the Apolipoprotein CIII gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am J Clin Nutr 68: 396-340, 1998

    PubMed  Google Scholar 

  46. Miller M: Differentiating the effects of raising low levels of high density lipoprotein cholesterol versus lowering normal TG: Further insights from the veterans affairs high density lipoprotein intervention trial. Am J Cardiol 86(suppl): 23L-27L, 2000

    Article  PubMed  Google Scholar 

  47. Morris SW, Price WH: DNA sequence polymorphisms in the apoAI/CIII gene cluster. Lancet ii: 1127-1128, 1986

    Google Scholar 

  48. Aalto-Setala K, Kontula K, Sane T, Nieminen M, Nikkila E: DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis 66: 145-152, 1987

    Article  PubMed  Google Scholar 

  49. Paulweber B, Friedl W, Krempler F, Humphries SE, Sandhofer F. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis 73: 125-133, 1988

    Article  PubMed  Google Scholar 

  50. Ordovas JM, Civeira F, Genest J: Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus: Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 87: 75-86, 1991

    Article  PubMed  Google Scholar 

  51. Rodigro E, González-LamuDo D, Ruiz JC, Fernández-Fresnedo G, Isia D, González-Cotorruelo J, Zubimendi JA, Francisco AL, Fuentes MG, Arias M: Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia and insulin resistance in renal transplantation. Am J transplant 2: 343-348, 2002

    Article  PubMed  Google Scholar 

  52. Kwiterovich PO Jr: Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 90: 30i-47i, 2002

    PubMed  Google Scholar 

  53. Lee S-J, Campos H, Lamuel A, Moye LA, Sacks FM: LDL containing Apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol 23: 853-858, 2003

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India

    S. Chhabra & N. Das

  2. Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India

    R. Narang, R. Lakshmy, S. Vasisht & S.C. Manchanda

  3. Institute of Human Genetics, University of Hamburg, Germany

    D.P. Agarwal

  4. Department of Biochemistry, Sir Ganga Ram Hospital, New Delhi, India

    M. Srivastava

Authors
  1. S. Chhabra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Narang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Lakshmy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Vasisht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D.P. Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S.C. Manchanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N. Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chhabra, S., Narang, R., Lakshmy, R. et al. Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD. Mol Cell Biochem 259, 59–66 (2004). https://doi.org/10.1023/B:MCBI.0000021345.31556.c9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000021345.31556.c9

Search

Navigation